Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://enzerna.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Gene Therapy - Enzerna Biosciences Inc - Nucleotide Expansion |
Description | Enzerna Biosciences Inc. develops gene therapies for nucleotide expansion disorders such as Myotonic Dystrophy and Huntington’s |
Keywords | N/A |
WebSite | enzerna.com |
Host IP | 160.153.48.7 |
Location | United States |
Site | Rank |
US$1,357,256
Last updated: 2023-05-12 06:50:27
enzerna.com has Semrush global rank of 7,798,314. enzerna.com has an estimated worth of US$ 1,357,256, based on its estimated Ads revenue. enzerna.com receives approximately 156,607 unique visitors each day. Its web server is located in United States, with IP address 160.153.48.7. According to SiteAdvisor, enzerna.com is safe to visit. |
Purchase/Sale Value | US$1,357,256 |
Daily Ads Revenue | US$1,253 |
Monthly Ads Revenue | US$37,586 |
Yearly Ads Revenue | US$451,027 |
Daily Unique Visitors | 10,441 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
enzerna.com. | A | 600 | IP: 160.153.48.7 |
enzerna.com. | NS | 3600 | NS Record: ns63.domaincontrol.com. |
enzerna.com. | NS | 3600 | NS Record: ns64.domaincontrol.com. |
enzerna.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
enzerna.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
enzerna.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
enzerna.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
enzerna.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
enzerna.com. | TXT | 3600 | TXT Record: NETORGFT7733494.onmicrosoft.com |
Home About Our Team Board of Directors Science Diseases Myotonic Dystrophy Huntington’s Disease Investors Contact Home About Our Team Board of Directors Science Diseases Myotonic Dystrophy Huntington’s Disease Investors Contact Pioneering Gene Therapies For Nucleotide Expansion Disorders Contact Us ASRE Technology Destroying Disease causing RNA Contact Us Targeting Disease MYOTONIC DYSTROPHY, HUNTINGTON DISEASE AND 20+ OTHER RELATED DISORDERS Learn More Our Company Gene Therapy by Enzerna Biosciences Inc. Enzerna Biosciences, Inc is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders. Our Target indications The Current Problem of Nucleotide Expansion Disorders Nucleotide expansion disorders, such as Myotonic Dystrophy and Huntington’s Disease , are genetic diseases that typically lead to progressive tissue loss. Life expectancy is about 20 years after clinical diagnosis. |
HTTP/1.1 301 Moved Permanently Date: Sat, 04 Dec 2021 08:32:31 GMT Server: Apache X-Powered-By: W3 Total Cache/2.2.0 Expires: Sat, 04 Dec 2021 09:32:32 GMT Cache-Control: max-age=3600 X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://enzerna.com/ Referrer-Policy: no-referrer-when-downgrade Content-Type: text/html; charset=UTF-8 HTTP/2 200 last-modified: Sat, 04 Dec 2021 07:12:20 GMT etag: "1e133-5d24cbe96ee6c" accept-ranges: bytes content-length: 123187 cache-control: max-age=0, public, public expires: Sat, 04 Dec 2021 08:32:32 GMT vary: Accept-Encoding,Cookie referrer-policy: no-referrer-when-downgrade x-powered-by: W3 Total Cache/2.2.0 pragma: public content-type: text/html; charset=UTF-8 date: Sat, 04 Dec 2021 08:32:32 GMT server: Apache |
Domain Name: ENZERNA.COM Registry Domain ID: 1878610354_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-10-03T17:15:59Z Creation Date: 2014-10-02T13:49:39Z Registry Expiry Date: 2022-10-02T13:49:39Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS63.DOMAINCONTROL.COM Name Server: NS64.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-09T08:37:49Z <<< |